tiprankstipranks
Argenx price target raised to $480 from $440 at Truist
PremiumThe FlyArgenx price target raised to $480 from $440 at Truist
5d ago
Argenx price target raised to EUR 390 from EUR 375 at Barclays
PremiumThe Fly
Argenx price target raised to EUR 390 from EUR 375 at Barclays
5d ago
Argenx price target raised to $512 from $463 at Citi
PremiumThe Fly
Argenx price target raised to $512 from $463 at Citi
6d ago
Argenx price target raised to $542 from $478 at Wells Fargo
PremiumThe FlyArgenx price target raised to $542 from $478 at Wells Fargo
6d ago
argenx Announces FDA Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy
PremiumPress Releases
argenx Announces FDA Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy
9d ago
Argenx announces FDA approval of VYVGART Hytrulo
PremiumThe Fly
Argenx announces FDA approval of VYVGART Hytrulo
9d ago
Jefferies biotech analyst holds an analyst/industry conference call
PremiumThe FlyJefferies biotech analyst holds an analyst/industry conference call
1M ago
Jefferies biotech analyst holds an analyst/industry conference call
PremiumThe Fly
Jefferies biotech analyst holds an analyst/industry conference call
1M ago
Jefferies biotech analyst holds an analyst/industry conference call
PremiumThe Fly
Jefferies biotech analyst holds an analyst/industry conference call
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100